News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
Laxxon Medical appoints Lauren Chung PhD MBA as Chief Financial Officer, signaling strategic expansion. Dr. Chung brings over 2 decades of healthcare industry experience and will enhance financial and operational management capabilities -
-
-
-
COMMUNIQUÉ DE PRESSE
Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
Napo Pharmaceuticals announces abstracts for two investigator-initiated studies on crofelemer for chronic refractory diarrhea patients, presented at ACG 2024. Jaguar CEO Lisa Conte comments on crofelemer's clinical robustness and impact on IBS-D patients
